Holen Sie sich die Stockscreener-App
9.74
3.75%
-0.38
Handel nachbörslich:
9.91
0.17
+1.75%
Finanzdaten der Monte Rosa Therapeutics Inc-Aktie (GLUE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
113.02%
8.968
|
4.21 | 2.781 | 12.77 | 23.19 |
| Operating Expenses |
7.10%
58.10
|
54.24 | 52.50 | 45.74 | 38.75 |
| Operating Income/Loss |
1.81%
-49.13
|
-50.03 | -49.72 | -32.98 | -15.55 |
| Nonoperating Income/Loss |
6.41%
5.941
|
5.583 | 3.639 | 2.717 | 4.458 |
| Income/Loss From Continuing Operations Before Tax |
2.84%
-43.19
|
-44.45 | -46.08 | -30.26 | -11.10 |
| Income Tax Expense/Benefit |
300.00%
0.208
|
0.052 | 0.059 | -3.177 | 1.199 |
| Net Income/Loss |
2.49%
-43.40
|
-44.50 | -46.13 | -27.08 | -12.29 |
| Basic Average Shares |
1.60%
101.48
|
99.88 | - | 82.40 | 82.19 |
| Diluted Average Shares |
1.60%
101.48
|
99.88 | - | 82.40 | 82.19 |
7.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):